Cancer Family
Central Nervous System Neoplasm
CI-CAN-00000118Explore in graph →
Non-malignant1,345 active trials7 approved drugs177 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000118Explore in graph →
Clinical trials
5,060 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03721055 | Fluoroglutamine PET/CT in Imaging Patients With Malignant Tumor | unknown | N/A | 60 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 6, 2019 | clinicaltrials |
| NCT02391246 | Radionecrosis and FDG PET(DTPI FDG-PET) | unknown | — | 62 | Ottawa Hospital Research InstituteOTHER | 1 | Aug 28, 2019 |
| clinicaltrials |
| NCT04066920 | IBER Salvage Treatment Followed by Ibrutinib Maintenance for Relapsed or Refractory PCNSL | unknown | Phase 2 | 30 | Deok-Hwan YangOTHER | 1 | Aug 26, 2019 | clinicaltrials |
| NCT04058704 | A Study to Determine the Efficiency For Brain Metastasis NSCLC Patients Treated With Icotinib Alone or Combined With Radiation Therapy(SMART) | unknown | Phase 3 | 296 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Aug 15, 2019 | clinicaltrials |
| NCT03997136 | Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas. | unknown | — | 28 | Assiut UniversityOTHER | 0 | Aug 7, 2019 | clinicaltrials |
| NCT03409549 | Multi-parametric MRI/Fluorine-18 Fluciclovine PET-CT in Glioblastoma | unknown | — | 12 | The Leeds Teaching Hospitals NHS TrustOTHER | 1 | Aug 6, 2019 | clinicaltrials |
| NCT03771625 | Evaluating Structural and Functional Changes of Brain by fMRI and DTI in Patients With Intracranial Germ Cell Tumors | unknown | — | 30 | Beijing Neurosurgical InstituteOTHER | 1 | Jul 29, 2019 | clinicaltrials |
| NCT03741244 | TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCT | unknown | Phase 2 | 211 | The Second Hospital of Hebei Medical UniversityOTHER | 1 | Jul 23, 2019 | clinicaltrials |
| NCT03778541 | HFSRT With Concurrent TMZ for Large BMs | unknown | Phase 3 | 224 | Chinese Academy of Medical SciencesOTHER | 1 | Jul 23, 2019 | clinicaltrials |
| NCT02393131 | Neurocognitive Outcome of Conformal WBRT w/wo Hippocampal Avoidance for Brain Metastases | unknown | N/A | 70 | National Taiwan University HospitalOTHER | 1 | Jul 19, 2019 | clinicaltrials |
| NCT02520635 | Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients | unknown | — | 180 | Beijing Tiantan HospitalOTHER | 1 | Jul 11, 2019 | clinicaltrials |
| NCT03392545 | Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1)(InSituVac1) | unknown | Phase 1 | 30 | Beijing Tiantan HospitalOTHER | 1 | Jul 11, 2019 | clinicaltrials |
| NCT04004975 | Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib | unknown | Phase 1 / Phase 2 | 50 | Shandong Cancer Hospital and InstituteOTHER | 1 | Jul 2, 2019 | clinicaltrials |
| NCT03971812 | Organoids Derived From Induced-Pluripotent Stem Cells (iPS) From Patients With High Grade Astrocytoma(GLIOMANOID) | unknown | — | 20 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Jun 13, 2019 | clinicaltrials |
| NCT03516162 | Linking Digital Smartphone Behaviour With Brain Function(SmartSurgery) | unknown | — | 100 | University of ZurichOTHER | 1 | May 24, 2019 | clinicaltrials |
| NCT03933241 | Nasal Irrigation Apply in Patients After Transsphenoidal Pituitary Tumor Resection | unknown | N/A | 262 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT03945682 | The ASsessment and Physiotherapy managEment of Ataxia in Children Following Surgical Resection of Posterior Fossa Tumour(ASPECT) | unknown | N/A | 40 | Alder Hey Children's NHS Foundation TrustOTHER | 1 | May 10, 2019 | clinicaltrials |
| NCT03916757 | V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer(GBM) | unknown | Phase 2 | 20 | Immunitor LLCINDUSTRY | 1 | Apr 17, 2019 | clinicaltrials |
| NCT03690570 | Long Term Follow up of Patients Under 5 Years of Age With High Grade Glioma Diagnosed in France Between 1990 and 2015(GlioUnder5) | unknown | — | 50 | University Hospital, Strasbourg, FranceOTHER | 1 | Apr 4, 2019 | clinicaltrials |
| NCT03402425 | The Diagnostic Value of 18F-FET PET/MRI for CNS Tumors in Children and Adolescents(BUF) | unknown | N/A | 200 | Rigshospitalet, DenmarkOTHER | 1 | Mar 28, 2019 | clinicaltrials |
| NCT03773705 | Impact of Nasoseptal Flap Harvest Technique on Olfaction Following Endoscopic Transsphenoidal Pituitary Surgery | unknown | N/A | 20 | Unity Health TorontoOTHER | 1 | Mar 15, 2019 | clinicaltrials |
| NCT03869242 | NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM(NovoTTF-200A) | unknown | N/A | 60 | Tel-Aviv Sourasky Medical CenterOTHER_GOV | 1 | Mar 11, 2019 | clinicaltrials |
| NCT03859544 | Molecular Prognosis of Lymphomas of the Central Nervous System (ALYCE-molecular)(ALYCEmolecular) | unknown | — | 74 | Hospices Civils de LyonOTHER | 1 | Mar 1, 2019 | clinicaltrials |
| NCT03687034 | A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma | unknown | Phase 1 | 21 | Leaf Vertical Inc.INDUSTRY | 0 | Feb 26, 2019 | clinicaltrials |
| NCT02209428 | A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas | unknown | Phase 2 | 54 | Huashan HospitalOTHER | 1 | Feb 21, 2019 | clinicaltrials |
| NCT02726568 | High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases | unknown | Phase 2 | 30 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 19, 2019 | clinicaltrials |
| NCT00863460 | Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young Patients(PRECIS) | unknown | Phase 2 | 140 | Institut CurieOTHER | 1 | Feb 5, 2019 | clinicaltrials |
| NCT03815838 | Molecular Imaging of Pituitary Adenomas(MIMOPA) | unknown | N/A | 20 | Cardiff UniversityOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT03091270 | ZOOMit-fMRI Identifies Motor Functional Cortex | unknown | — | 60 | Beijing Neurosurgical InstituteOTHER | 1 | Jan 16, 2019 | clinicaltrials |
| NCT03780569 | TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM | unknown | N/A | 10 | NovoCure Ltd.INDUSTRY | 1 | Dec 20, 2018 | clinicaltrials |
| NCT03642080 | MRI Predictors of Response to Tumor Treating Fields | unknown | — | 48 | New York Presbyterian Brooklyn Methodist HospitalOTHER | 1 | Dec 19, 2018 | clinicaltrials |
| NCT02652897 | Hemostasis Alterations in Neurosurgical Patients(ABCD) | unknown | — | 120 | Santiago R. Leal-NovalOTHER | 1 | Nov 27, 2018 | clinicaltrials |
| NCT03754530 | Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation | unknown | Phase 2 | 162 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 0 | Nov 27, 2018 | clinicaltrials |
| NCT03717454 | Dopamine D2 Receptors(D2R) Imaging in Prolactinomas | unknown | N/A | 50 | Zhebao WuOTHER | 0 | Nov 20, 2018 | clinicaltrials |
| NCT03746288 | To Evaluate the Efficacy and Safety of CAN008 Combined With Re-irradiation (rRT) for Treating Patients With Recurrent Glioblastoma (GBM) | unknown | Phase 2 | 60 | CANbridge Life Sciences Ltd.INDUSTRY | 0 | Nov 19, 2018 | clinicaltrials |
| NCT03733327 | BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT | unknown | Phase 2 / Phase 3 | 20 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Nov 7, 2018 | clinicaltrials |
| NCT03719781 | Postoperative Cognitive Dysfunction in Patients Undergoing Pituitary Removal Surgery | unknown | — | 90 | Kocaeli UniversityOTHER | 1 | Oct 25, 2018 | clinicaltrials |
| NCT03717766 | Application of New Technologies in the Resection of Intracranial Tumors | unknown | — | 100 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauOTHER | 0 | Oct 24, 2018 | clinicaltrials |
| NCT03716986 | Multimodal Imaging of Hypoxia in Gliomas(GLIOXYMAGE) | unknown | N/A | 20 | University Hospital, CaenOTHER | 1 | Oct 23, 2018 | clinicaltrials |
| NCT03714347 | The Effect of Cerebral Oxygenation on Postoperative Recovery in Intracranial Surgery(Oxygenation) | unknown | N/A | 100 | Trakya UniversityOTHER | 1 | Oct 22, 2018 | clinicaltrials |
| NCT03714763 | Dopamine D2 Receptors(D2R) Imaging in Nonfunctioning Pituitary Adenoma(NFPA) | unknown | N/A | 50 | Zhebao WuOTHER | 0 | Oct 22, 2018 | clinicaltrials |
| NCT02933333 | G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor | unknown | Phase 4 | 405 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 17, 2018 | clinicaltrials |
| NCT02672241 | Nimotuzumab in Combination With Radio-chemotherapy for the Treatment of Brainstem Tumor in Children | unknown | Phase 2 | 30 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 16, 2018 | clinicaltrials |
| NCT03400865 | Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas | unknown | N/A | 30 | Zhebao WuOTHER | 1 | Oct 16, 2018 | clinicaltrials |
| NCT03675230 | Study of Tomotherapy HD in Medulloblastoma | unknown | N/A | 220 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 18, 2018 | clinicaltrials |
| NCT03668522 | Clinical Research of H3F3AK27M in Spinal Glioma and Its Impact on TMZ Chemoradiotherapy | unknown | — | 60 | Southern Medical University, ChinaOTHER | 1 | Sep 12, 2018 | clinicaltrials |
| NCT03247127 | Memory Preservation of Hippocampal Avoidance Whole Brain Radiotherapy | unknown | N/A | 30 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Aug 28, 2018 | clinicaltrials |
| NCT03641391 | Awake Intraoperative Language Mapping and Chinese Probabilistic Map Construction | unknown | N/A | 300 | Huashan HospitalOTHER | 1 | Aug 22, 2018 | clinicaltrials |
| NCT03631836 | Phase I Study of Monoclonal Antibondy (GS) 5745, an Matix Metalloproteinase 9 (MMP9) Mab Inhibitor, in Combination With Bevacizumab in Patients With Recurrent Glioblastoma(MARELLE01) | unknown | Phase 1 | 34 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Aug 17, 2018 | clinicaltrials |
| NCT03633552 | Efficacy of Two Temozolomide Regimens in Adjuvant Treatment of Patients With Brain High Grade Glioma | unknown | Phase 3 | 62 | Mashhad University of Medical SciencesOTHER | 1 | Aug 16, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Sep 6, 2019source: clinicaltrials